| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |